A Randomised Comparison of Bicalutamide ('Casodex') 150 mg versus Placebo as Immediate Therapy Either Alone or as Adjuvant to Standard Care for Early Non-Metastatic Prostate Cancer First Report from the Scandinavian Prostatic Cancer Group Study No. 6
- 1 September 2002
- journal article
- clinical trial
- Published by Elsevier in European Urology
- Vol. 42 (3) , 204-211
- https://doi.org/10.1016/s0302-2838(02)00311-1
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: